PhRMAFoundation
The PhRMA Foundation is a 501(c)(3) nonprofit organization that fosters biopharmaceutical innovation and value-driven health care by investing in the frontiers of research. The Foundation catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships in the fields of drug delivery, drug discovery, translational medicine, and value assessment and health outcomes research.
Q&A with Miao Cao: Boosting the Efficacy of CAR T Cell Therapy for Colorectal Cancer
Q&A with Maria Hudock: Cracking the Case on Gene Therapy for Cystic Fibrosis
Q&A with Anh Cong: Finding Drugs to Protect the Heart During Chemotherapy
Q&A with Texia Loh: Targeting Cancer’s DNA Repair Process to Improve Small Cell Lung Cancer Therapy
Q&A with Alina Ringaci: Improving Antibody-Drug Conjugates for Cancer Treatment
Q&A with Dr. Allison Siegenfeld: Understanding a Tiny RNA Modification's Outsized Role in Cancer
Q&A with Dr. Lisa Volpatti: Turning Bad Cholesterol Into a Good Drug Delivery Vehicle
Q&A with Dr. Yu-Hsiang Chen: Tracking Residual Cancer Cells After Treatment to Prevent Relapse
Empowering MS Patients to Confidently Engage in Value Assessment Research
Q&A with Tim Lai: Leveraging Real-World Data and Patient Preferences to Improve Depression Treatment
Q&A with Annalisa Ferrotta: Understanding Glioblastoma Treatment Failures and Evaluating New Options
Q&A with Sola Olawore: Evaluating Long-Term Safety of Antenatal Corticosteroids for Preterm Birth
Engaging Patients in Value Assessment and Health Outcomes Research
Q&A with Thomas Kuret: A New Approach to Protect Brain Cells From Parkinson’s Disease
Q&A with Dr. Shamimur Akanda: Computational Modeling to Predict Drug Behavior in Joint Diseases
Q&A with Eleanor Agosta: Identifying a Novel Biomarker for Cervical Cancer Progression
Q&A with Jacob Capener: Targeting Understudied Proteins for Cancer Drug Development
Q&A with Dr. Noor Momin: Personalized Medicine for Atrial Fibrillation
Q&A with Dr. Elizabeth Brunk: Using AI and Single Cell Imaging to Halt Harmful DNA Changes in Cancer
Q&A with Dr. Erick Rodriguez-Palma: Targeting Ion Channels for Fibromyalgia Treatment
Q&A with Ameya Chaudhari: Designing Innovative Meshes for Accelerated Diabetic Wound Healing
Q&A with Dr. Zhimin Huang: Engineering a Noninvasive, Targeted Approach to Treating Brain Diseases
PhRMA Foundation Award Recipient Survey: 60 Years of Launching Careers
Q&A with Shruti Dharmaraj: Developing Molecules to Treat Allergic Reactions
PhRMA Foundation: Investing in Future Leaders
Q&A with Alan Ardito: Investigating Malaria’s Impact on the Brain to Find Therapeutic Targets
Q&A with Bernardo Aguzzoli Heberle: Studying RNA to Find Molecular Targets for Alzheimer’s Treatment
Q&A with Nha Tran: Empowering Older Adults with Diabetes to Discuss Deprescribing with Doctors
Q&A with Azlann Arnett: Reprogramming CAR T Cells to Overcome Barriers in Treating Solid Tumors
Informational Session: 2026 PhRMA Foundation Funding Opportunities & Application Process